AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
AstraZeneca has unveiled plans to invest £2bn in Beijing months after Chinese authorities detained the company’s local boss ...
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...
British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention ...
AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...
AstraZeneca announced on Friday an investment of $2.5 billion in Beijing to establish the pharmaceutical company's sixth ...
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
AstraZeneca (AZN) announced an investment of $2.5B in Beijing to establish its sixth global strategic R&D center together with major ...
AstraZeneca (AZN) stock in focus as the company invests $2.5B in Beijing for a new R&D center, strengthening its footprint in ...
Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results